These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23319673)

  • 21. Tranexamic acid and convulsive seizures after off-pump coronary artery bypass surgery: the role of renal insufficiency.
    Hulde N; Zittermann A; Deutsch MA; von Dossow V; Gummert JF; Koster A
    Interact Cardiovasc Thorac Surg; 2019 Dec; 29(6):852-854. PubMed ID: 31408168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pro: Antifibrinolytics Should Be Used in Routine Cardiac Cases Using Cardiopulmonary Bypass (Unless Contraindicated).
    Pustavoitau A; Faraday N
    J Cardiothorac Vasc Anesth; 2016 Jan; 30(1):245-7. PubMed ID: 26619951
    [No Abstract]   [Full Text] [Related]  

  • 23. Tranexamic acid: a clinical review.
    Ng W; Jerath A; Wąsowicz M
    Anaesthesiol Intensive Ther; 2015; 47(4):339-50. PubMed ID: 25797505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
    Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ε-Aminocaproic acid and clinical value in cardiac anesthesia.
    Raghunathan K; Connelly NR; Kanter GJ
    J Cardiothorac Vasc Anesth; 2011 Feb; 25(1):16-9. PubMed ID: 20870423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re-evaluation of the role of antifibrinolytic therapy with lysine analogs during cardiac surgery in the post aprotinin era.
    Koster A; Schirmer U
    Curr Opin Anaesthesiol; 2011 Feb; 24(1):92-7. PubMed ID: 20881484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery.
    Lin CY; Shuhaiber JH; Loyola H; Liu H; Del Nido P; DiNardo JA; Pigula FA
    PLoS One; 2015; 10(5):e0126514. PubMed ID: 25954976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass.
    Wesley MC; Pereira LM; Scharp LA; Emani SM; McGowan FX; DiNardo JA
    Anesthesiology; 2015 Apr; 122(4):746-58. PubMed ID: 25585004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors associated with postoperative seizures in patients undergoing cardiac surgery who received tranexamic acid: a case-control study.
    Montes FR; Pardo DF; Carreño M; Arciniegas C; Dennis RJ; Umaña JP
    Ann Card Anaesth; 2012; 15(1):6-12. PubMed ID: 22234015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural and synthetic antifibrinolytics: inert, poisonous or therapeutic agents?
    Hardy JF; Bélisle S
    Can J Anaesth; 1997 Sep; 44(9):913-7. PubMed ID: 9305552
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of epsilon aminocaproic acid and tranexamic Acid in thoracic aortic surgery: clinical efficacy and safety.
    Makhija N; Sarupria A; Kumar Choudhary S; Das S; Lakshmy R; Kiran U
    J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1201-7. PubMed ID: 24050855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tranexamic acid: how much is enough?
    Fox MA
    Anesth Analg; 2010 Aug; 111(2):580-1; author reply 581. PubMed ID: 20664102
    [No Abstract]   [Full Text] [Related]  

  • 33. Are tranexamic acid and ε-aminocaproic acid adequate substitutes for aprotinin?
    Tempe DK; Hasija S
    Ann Card Anaesth; 2012; 15(1):4-5. PubMed ID: 22234014
    [No Abstract]   [Full Text] [Related]  

  • 34. Safety of tranexamic acid in pediatric cardiac surgery: what we do not know.
    Faraoni D
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1550-1; author reply 1551-2. PubMed ID: 21497106
    [No Abstract]   [Full Text] [Related]  

  • 35. Antifibrinolytic therapy with tranexamic acid in cardiac operations.
    Matsuzaki K; Matsui K; Tanoue Y; Nagano I; Haraguchi N; Tatewaki H
    Cardiovasc Surg; 1999 Mar; 7(2):195-9. PubMed ID: 10353670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The post-BART anti-fibrinolytic dilemma?
    Beattie WS; Karkouti K
    J Cardiothorac Vasc Anesth; 2011 Feb; 25(1):3-5. PubMed ID: 21272775
    [No Abstract]   [Full Text] [Related]  

  • 37. Associations of preoperative stroke and tranexamic acid administration with convulsive seizures in valvular open-heart surgery.
    Hulde N; Zittermann A; Deutsch MA; von Dossow V; Gummert JF; Koster A
    J Anesth; 2021 Jun; 35(3):451-454. PubMed ID: 33822280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What's New for Tranexamic Acid?
    Muschart X; Vincent P
    J Emerg Med; 2016 Sep; 51(3):332-3. PubMed ID: 27386801
    [No Abstract]   [Full Text] [Related]  

  • 39. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of tranexamic acid in patients undergoing cardiac surgery with use of cardiopulmonary bypass.
    Sharma V; Fan J; Jerath A; Pang KS; Bojko B; Pawliszyn J; Karski JM; Yau T; McCluskey S; Wąsowicz M
    Anaesthesia; 2012 Nov; 67(11):1242-50. PubMed ID: 22827564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.